197 related articles for article (PubMed ID: 18607213)
1. Pathophysiology of Huntington's disease: from huntingtin functions to potential treatments.
Roze E; Saudou F; Caboche J
Curr Opin Neurol; 2008 Aug; 21(4):497-503. PubMed ID: 18607213
[TBL] [Abstract][Full Text] [Related]
2. Huntingtin and its role in neuronal degeneration.
Li SH; Li XJ
Neuroscientist; 2004 Oct; 10(5):467-75. PubMed ID: 15359012
[TBL] [Abstract][Full Text] [Related]
3. Huntington's disease: clinical characteristics, pathogenesis and therapies.
Nakamura K; Aminoff MJ
Drugs Today (Barc); 2007 Feb; 43(2):97-116. PubMed ID: 17353947
[TBL] [Abstract][Full Text] [Related]
4. Axonal transport failure in neurodegenerative disorders: the case of Huntington's disease.
Charrin BC; Saudou F; Humbert S
Pathol Biol (Paris); 2005 May; 53(4):189-92. PubMed ID: 15850950
[No Abstract] [Full Text] [Related]
5. Clinical Genetics, II. Huntington's disease: from the gene to pathophysiology.
DiFiglia M
Am J Psychiatry; 1997 Aug; 154(8):1046. PubMed ID: 9247386
[No Abstract] [Full Text] [Related]
6. CYP46A1 gene therapy deciphers the role of brain cholesterol metabolism in Huntington's disease.
Kacher R; Lamazière A; Heck N; Kappes V; Mounier C; Despres G; Dembitskaya Y; Perrin E; Christaller W; Sasidharan Nair S; Messent V; Cartier N; Vanhoutte P; Venance L; Saudou F; Néri C; Caboche J; Betuing S
Brain; 2019 Aug; 142(8):2432-2450. PubMed ID: 31286142
[TBL] [Abstract][Full Text] [Related]
7. Does tissue transglutaminase play a role in Huntington's disease?
Lesort M; Chun W; Tucholski J; Johnson GV
Neurochem Int; 2002 Jan; 40(1):37-52. PubMed ID: 11738471
[TBL] [Abstract][Full Text] [Related]
8. Normal huntingtin function: an alternative approach to Huntington's disease.
Cattaneo E; Zuccato C; Tartari M
Nat Rev Neurosci; 2005 Dec; 6(12):919-30. PubMed ID: 16288298
[TBL] [Abstract][Full Text] [Related]
9. Update on Huntington's disease.
Berman SB; Greenamyre JT
Curr Neurol Neurosci Rep; 2006 Jul; 6(4):281-6. PubMed ID: 16822347
[TBL] [Abstract][Full Text] [Related]
10. [Pathophysiology of Huntington's disease: an update].
Roze E; Betuing S; Deyts C; Vidailhet M; Caboche J
Rev Neurol (Paris); 2008 Dec; 164(12):977-94. PubMed ID: 18808762
[TBL] [Abstract][Full Text] [Related]
11. Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington's disease.
Weiss A; Klein C; Woodman B; Sathasivam K; Bibel M; Régulier E; Bates GP; Paganetti P
J Neurochem; 2008 Feb; 104(3):846-58. PubMed ID: 17986219
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease.
Lee WC; Yoshihara M; Littleton JT
Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3224-9. PubMed ID: 14978262
[TBL] [Abstract][Full Text] [Related]
13. Are there multiple pathways in the pathogenesis of Huntington's disease?
Aronin N; Kim M; Laforet G; DiFiglia M
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):995-1003. PubMed ID: 10434298
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of endoplasmic reticulum stress counteracts neuronal cell death and protein aggregation caused by N-terminal mutant huntingtin proteins.
Reijonen S; Putkonen N; Nørremølle A; Lindholm D; Korhonen L
Exp Cell Res; 2008 Mar; 314(5):950-60. PubMed ID: 18255062
[TBL] [Abstract][Full Text] [Related]
15. [Huntington chorea in Drosophila and mice: toward new therapeutic steps].
Liévens JC; Birman S
Med Sci (Paris); 2003 May; 19(5):593-9. PubMed ID: 12836393
[TBL] [Abstract][Full Text] [Related]
16. Genetic interaction between expanded murine Hdh alleles and p53 reveal deleterious effects of p53 on Huntington's disease pathogenesis.
Ryan AB; Zeitlin SO; Scrable H
Neurobiol Dis; 2006 Nov; 24(2):419-27. PubMed ID: 16978870
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic modifications as novel therapeutic targets for Huntington's disease.
Wang F; Fischhaber PL; Guo C; Tang TS
Epigenomics; 2014 Jun; 6(3):287-97. PubMed ID: 25111483
[TBL] [Abstract][Full Text] [Related]
18. Huntingtin-protein interactions and the pathogenesis of Huntington's disease.
Li SH; Li XJ
Trends Genet; 2004 Mar; 20(3):146-54. PubMed ID: 15036808
[TBL] [Abstract][Full Text] [Related]
19. Huntington's disease.
Ha AD; Fung VS
Curr Opin Neurol; 2012 Aug; 25(4):491-8. PubMed ID: 22772878
[TBL] [Abstract][Full Text] [Related]
20. Reversal of a full-length mutant huntingtin neuronal cell phenotype by chemical inhibitors of polyglutamine-mediated aggregation.
Wang J; Gines S; MacDonald ME; Gusella JF
BMC Neurosci; 2005 Jan; 6():1. PubMed ID: 15649316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
